Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 44 days ago
Share
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
428 patients around the world
Available in
Chile, United States
Amgen
2
Research sites
428
Patients around the world
This study is for people with
Asthma
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Centro de Investigación del Maule - Talca
Recruiting
Consult
View site
9 1/2 Oriente #1457. Talca
View site
Consult
Icegclinic Research & Care
Recruiting
Consult
View site
Serafín Zamora 190, Torre B, piso 4, Oficina 14. Clínica Vespucio, La Florida
View site
Consult
See details
Contact us
Contact us
Sponsor
Amgen
Conditions
Requirements
To 75 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06376045
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent